News
14hon MSN
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...
HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...
The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...
A study led by Harvard Medical School, explored the reason that causes the rise of aortic aneurysms, thus offering vital ...
The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable. This new drug promises better adherence and wider access, especially in ...
17h
ABP - Live on MSNIndia assures Sri Lanka of evacuating its nationals from Iran amid Middle East tensionsIndia pledges to evacuate Sri Lankan nationals from Iran during the Israel conflict, reinforcing Indo-Sri Lankan ties.
17h
NDTV Profit on MSN‘Peace through strength’, Trump’s leadership created pivot of history: NetanyahuIsraeli PM Benjamin Netanyahu praises US President Donald Trump for striking Iran's nuclear facilities, foreseeing a future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results